ESMO ImmunoOncology Congress showcases novel technologies set to benefit many cancer patients
ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients
Innovation in immuno-oncology is exploding and new technologies that are set to benefit many patients with cancer are being showcased in the highly diverse array of topics to be discussed at the ESMO Immuno-Oncology Congress, to be held 13-16 December in Geneva, Switzerland.
More From BioPortfolio on "ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients"